Simon J. Harrison

305 Grattan Street
Melbourne, VIC 3000, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 239 publications

Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL.

Shortened axi-cel manufacturing drives rapid in vivo expansion and shifts the acute toxicity profile in R/R LBCL.

Journal: Blood advances

Published: June 29, 2026

Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

Dynamic risk stratification using early CAR-T expansion in R/R LBCL treated with axicabtagene ciloleucel.

Journal: British journal of haematology

Published: June 20, 2026

Diet and risk of multiple myeloma: findings from a case-control study.

Diet and risk of multiple myeloma: findings from a case-control study.

Journal: The British journal of nutrition

Published: May 13, 2026

Developing a neuropsychiatry curriculum for clinical psychologists and neuropsychologists: An e-Delphi study.

Developing a neuropsychiatry curriculum for clinical psychologists and neuropsychologists: An e-Delphi study.

Journal: Journal of neuropsychology

Published: April 15, 2026

Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort study.

Persistent and pathogen-specific infection risk during long-term survivorship after CD19 CAR-T: An Australian multi-centre cohort study.

Journal: Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases

Published: March 10, 2026

Infections in the First 30 Days after Chimeric Antigen Receptor T-Cell Therapy in Patients Not Receiving Fluoroquinolone Prophylaxis.

Infections in the First 30 Days after Chimeric Antigen Receptor T-Cell Therapy in Patients Not Receiving Fluoroquinolone Prophylaxis.

Journal: Transplantation and cellular therapy

Published: January 24, 2026

Cytomegalovirus reactivation in patients with multiple myeloma receiving bispecific antibodies.

Cytomegalovirus reactivation in patients with multiple myeloma receiving bispecific antibodies.

Journal: Blood advances

Published: January 05, 2026

Neurological implications of chimeric antigen receptor-T cell therapy.

Neurological implications of chimeric antigen receptor-T cell therapy.

Journal: BMJ neurology open

Published: December 10, 2025

Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.

Reply to: The chemotherapeutic drug CX-5461 is a potent mutagen in cultured human cells.

Journal: medRxiv : the preprint server for health sciences

Published: November 19, 2025

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Journal: Blood

Published: November 04, 2025

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Time of infusion does not significantly impact outcomes following CAR T-cell therapy in large B-cell lymphoma.

Journal: Blood

Published: November 04, 2025

Psychiatry and the future: Expertise, Artificial Intelligence, and emerging technologies.

Psychiatry and the future: Expertise, Artificial Intelligence, and emerging technologies.

Journal: International review of psychiatry (Abingdon, England)

Published: October 25, 2025

Showing 1-12 of 239

Last Updated: 09/26/2026